| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_134aaa322d94889185d1365c3ead7409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06641619458d12494196faf8798049fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dea92dbfc469e1377d9483aa576b8c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c8dd1fa903c24f4a28439aca677ecb |
| publicationDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004050034-A2 |
| titleOfInvention |
Prolonged suppression of electrical activity in excitable tissues |
| abstract |
Controlled release of pharmaceutical agents using microspheres or other controlled release systems are used to treat disease state characterized by aberrant electrical activity in excitable tissue. For the treatment of epilepsy, agents useful in the treatment of epilepsy may be delivered to the patient at the site of seizure origin to control seizure activity in a time release manner. The inventive system may also be useful in the treatment of cardiac arrhythmias and pre-term labor. Particularly useful pharmaceutical compositions comprising a site 1 sodium channel blocker are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018064498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9849116-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10028940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980783-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8518926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007096170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9468630-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285981-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1844781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828284-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026928-B2 |
| priorityDate |
2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |